Avalon Laboratories Receives FDA And European Clearance To Market Three Catheter Devices Used In Extracorporeal Life ... (Medical News Today)
Avalon Laboratories, LLC (Avalon) has announced that it has received 510(k) clearances from the U.S. Food and Drug Administration (FDA) and CE Mark acceptance from the European Union for three new catheter devices used in medical life support systems. The clearances enable Avalon to begin distributing these products to hospitals and health care systems in the United States and the European Union.

Aurobindo, Orchid, Lupin and Glenmark receive US FDA nod for Levetiracetam (PharmaBiz)
Four Indian pharma majors, Aurobindo Pharma, Orchid Chemicals and Pharmaceuticals, Lupin Ltd and Glenmark Pharmaceuticals have received the US FDA approval for Abbreviated New Drug Application (ANDA) for marketing and distribution of Levetiracetam tablets of 250 mg, 500 mg and 750 mg range in the US market.